Wenyu Zhu

This inventor holds 45 USPTO granted patents and 24 published patent applications, plus 8 CIPO patents and 14 EPO patents, primarily in Immunomodulator Compounds. Top assignees: Incyte Corporation, Incyte Holdings Corporation. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wenyu Zhu. Retrieved from https://idiyas.com/inventor/wenyu-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 45 (Patent Applications = 24)

% Patents Active = 88.9

CIPO Patents = 8 (Patent Applications = 13)

EPO Patents = 14 (Patent Applications = 30)

Average Co-Inventor Count = 5.3

ph-index = 15

Forward Citations = 820(Granted Patents)

Location History:

Media, PA (US) (2006 - 2024)
Wilmington, DE (US) (2022 - 2024)

Company Filing History:

Incyte Holdings Corporation

patents

where one patent can have more than one assignee

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

Immunomodulators

KRAS Inhibitors

JAK Inhibitors

Heterocyclic Compounds

Quinoline Compounds

Oxadiazoles

Pim Kinase Inhibitors

Tricyclic Derivatives

Fused Pyrazine

Pyrazoloquinoline

Indoleamine Inhibitors

Cyclobutyl Derivatives

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735424 - Fused pyrazine derivatives as A2A / A2B inhibitors (2026-09-15),

2. 12466822 - Heterocyclic compounds as immunomodulators (2025-11-11),

3. 12378243 - Quinoline compounds as inhibitors of KRAS (2025-08-05),

4. 12060433 - CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy (2024-08-13),

5. 12030884 - Pyrazoloquinoline KRAS inhibitors (2024-07-09),

6. 12030883 - Hetero-tricyclic compounds as inhibitors of KRAS (2024-07-09),

7. 11999740 - Fused pyrazine derivatives as A2A / A2B inhibitors (2024-06-04),

8. 11939328 - Quinoline compounds as inhibitors of KRAS (2024-03-26),

9. 11851442 - Tricyclic fused thiophene derivatives as JAK inhibitors (2023-12-26),

10. 11530218 - Spiro compounds as inhibitors of KRAS (2022-12-20),

11. 11207302 - 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase (2021-12-28),

12. 11161855 - Tricyclic fused thiophene derivatives as JAK inhibitors (2021-11-02),

13. 11161850 - Fused pyrazine derivatives as A2A / A2B inhibitors (2021-11-02),

14. 11053215 - Heterocyclic compounds useful as Pim kinase inhibitors (2021-07-06),

15. 10806785 - Immunomodulator compounds and methods of use (2020-10-20),

Title: The Innovative Journey of Wenyu Zhu

Introduction:

Wenyu Zhu, a talented inventor hailing from Media, PA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents:

Wenyu Zhu's latest patents include a cutting-edge software application for data encryption and a revolutionary device for enhancing solar energy efficiency.

Career Highlights:

With a career spanning over two decades, Wenyu Zhu has established himself as a visionary in the tech industry. He has led numerous research projects that have resulted in game-changing inventions.

Collaborations:

Throughout his career, Wenyu Zhu has collaborated with leading tech companies and research institutions to bring his ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in his success.

Conclusion:

In conclusion, Wenyu Zhu's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in the technology sector. His contributions continue to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.